View Author
peptide imaging activity receptor 68 ga 68 ge activity uptake analogue generator study tumour eluate breeman patient cancer 18 f-fch 68 ga activity /68ga radioactivity tumour uptake column tissue analog prostate netherland blood f-fch tumor concentration 68 ga-amba 68 ge jong m elution injection waste volume result 68 ga-labeled pharmaceuticals radionuclide radiolabelled prostate cancer demobesin medicine sorption application ga-amba therapy stability fication amount radiolabeled binding administration ratio system tumours ga-labeled fraction biodistribution internalization kidney desorption 24 h p.i positron emission tomography 1 h p.i anion time points somatostatin radiolabelling bombesin point antagonist dota-peptide sample radiopharmaceutical waser b pesin choline 111 in-dota-mg 11 effect
7 Most Recent Publications
|
Comparison of the binding and internalization properties of 12 DOTA-coupled and
111In-labelled CCK2/gastrin receptor binding peptides: A collaborative project under COST Action BM0607
(Article)
Aloj, L. Aurilio, M. Sosabowski, J.K. Breeman, W.A.P. Blois, E. de Koelewijn, S. Melis, M.L. Waser, B. Beetschen, K. Reubi, J.C. Jong, M. de Rinaldi, V. D'ambrosio, L. Tesauro, D. Peitl, P.K. Maina, T. Mansi, R. Guggenberg, E. von Joosten, L. |
2011-08-01
|
|
Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts
(Article)
Schroeder, R.P.J. Weerden, W.M. van Jong, M. de Krenning, E.P. Bangma, C.H. Berndsen, S.C. Grievink-De Ligt, C.H. Groen, H.C. Reneman, S. Blois, E. de Breeman, W.A.P. |
2011-07-01
|
|
68Ga-labeled DOTA-peptides and
68Ga-labeled radiopharmaceuticals for positron emission tomography: Current status of research, clinical applications, and future Perspectives
(Article)
Breeman, W.A.P. Blois, E. de Sze Chan, H. Konijnenberg, M. Kwekkeboom, D.J. Krenning, E.P. |
2011-07-01
|
|
Reduction of 68Ge activity containing liquid waste from 68Ga PET chemistry in nuclear medicine and radiopharmacy by solidification
(Article)
Blois, E. de Chan, H.S. Roy, K. Krenning, E.P. Breeman, W.A.P. |
2011-04-01
|
|
Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides
(Article)
Blois, E. de Sze Chan, H. Naidoo, C. Prince, D. Krenning, E.P. Breeman, W.A.P. |
2011-02-01
|
|
A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues
(Article)
Schroeder, R.P.J. Müller, C. Reneman, S. Melis, M.L. Breeman, W.A.P. Blois, E. de Bangma, C.H. Krenning, E.P. Weerden, W.M. van Jong, M. de |
2010-07-01
|
|
Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides
(Article)
Breeman, W.A.P. Fröberg, A.C. Krenning, E.P. Blois, E. de Gameren, A. van Melis, M.L. Jong, M. de Maina, T. Nock, B.A. Erion, J.L. Mäcke, H.R. |
2008-11-01
|
